© MIP Discovery

MIP Discovery Ltd has closed a £7M Series A financing to drive commercialisation of its synthetic affinity reagents in cell and gene therapy.

Chart of the penny stock Vidac Pharma Holdings. © onvista.de

London-based Vidac Pharma Holding plc reported that its Warburg effect blocker VDA-1275 increased efficacy of chemotherapeutics 1000-fold in human organoid cancer models for liver cancer.

PharmaCongress_2024_EBN.jpg

In addition to classic aseptic manufacturing topics, the international GMP PharmaCongress and GMP Pharmatechnica Expo 2024 in Wiesbaden will also address global challenges with modern vaccines and novel drugs based on cell and gene therapies. The event thus offers a comprehensive programme for experts from pharmaceutical manufacturing, technology and quality assurance from industry, labs and authorities, as well as a platform for the direct exchange of knowledge and experience.

© Freenome Inc

Multi-omics liquid biospy specialist Freenome Inc. has baged US$254m in a financing round led by Roche AG to fund early cancer detection in 6,200 patients using its AI-guided cancer detection platform.

Annual production capacity of bioplastics. @ EUBP/Nova Institute

New figures published by the industry association European Bioplastics suggest a sharp increase in the production of sustainable plastics in the next two years and calls for policy support.

Photo: Bactiguard AB

Christine Lind will join Stockholm-based Bactiguard AB as new CEO at the Annual General Meeting in mid-May.

© AZmed

Paris-based AI-based medical imanging specialist AZmed SA has secured a €15min Series A financing led by Maison Worms, Techstars, and Tempact Ventures.

AskBio Europe headquarternatnRoslin Innovation Centre/Easter Bush Campus. © Ask Bio Inc

Bayer SE subsidiary Asklepios BioPharmaceutical Inc. (AskBio) has started Phase II testing of AB-1002 (NAN-101) in patients with congestive heart failure. 

© Alessandro_Grandini - Freepik.com

German Green Elephant Biotech has launched the world’s first plant-based 96-well microtitre plate on the market.

Amplys team around CEO Ben Thomas (4th from left). © Amply Discovery Ltd

Belfast-based techbio company AMPLY Discovery Ltd announced today will make use of a £1.4m in grant funding to advance its AI-based drug discovery platform.